User:Mr. Ibrahem/Netarsudil

Netarsudil, sold under the brand name Rhopressa and Rhokiinsa, is a medication used to treat increased intraocular pressure including open-angle glaucoma. It is used as an eye drop.

Common side effects include red eyes, conjunctival bleeding, blurry vision, and tearing. Other side effects may include bacterial keratitis. It is a rho kinase inhibitor.

Netarsudil was approved for medical use in the United States in 2017 and Europe in 2019. In the United States a 2.5 ml bottle costs about 305 USD as of 2021. It is also available as the combination netarsudil/latanoprost. It is not commercially available in Europe and the United Kingdom as of 2021.